Skip to main content
. 2023 May 9;12(10):3356. doi: 10.3390/jcm12103356

Table 1.

Patients’ characteristics of the included studies.

Variable Total
(n = 53)		 Females
(n = 38)		 Males
(n = 15)		 p-Value Benign
(n = 24)		 Malignant
(n = 29)		 p-Value Left
(n = 27)		 Right
(n = 23)		 p-Value
Age 43.72 ± 17.76 44.68 ± 15.31 41.27 ± 23.31 0.533 49.17 ± 15.65 39.21 ± 18.39 0.041 40.59 ± 16.71 45.35 ± 18.99 0.351
Male sex 15 (28.3%) - 15 (100%) - 6 (25.0%) 9 (31.0%) 0.858 8 (29.6%) 5 (21.7%) 0.756
Previous cancer 10 (19.2%) 6 (16.7%) 4 (26.7%) 0.633 5 (20.8%) 5 (17.9%) 0.999 3 (11.1%) 5 (22.7%) 0.480
Malignant 29 (54.7%) 20 (52.6%) 9 (60.0%) 0.858 - 29 (100%) - 20 (74.1%) 8 (34.8%) 0.012
Metastasis 5 (9.4%) 3 (7.9%) 2 (13.3%) 0.929 0 (0.0%) 5 (17.2%) 0.096 2 (7.4%) 2 (8.7%) 0.999
Position 0.261 0.203 0.256

  • Atrium

35 (66.0%) 25 (65.8%) 10 (66.7%) 18 (75.0%) 17 (58.6%) 17 (63.0%) 16 (69.6%)

  • Ventricle

15 (28.3%) 12 (31.6%) 3 (20.0%) 6 (25.0%) 9 (31.0%) 7 (25.9%) 7 (30.4%)

  • Valve

3 (5.7%) 1 (2.6%) 2 (13.3%) 0 (0.0%) 3 (10.3%) 3 (11.1%) 0 (0.0%)
Heart side 0.261 0.016

  • Left

27 (50.9%) 19 (50.0%) 8 (53.3%) 7 (29.2%) 20 (69.0%)

  • Right

23 (43.4%) 18 (47.4%) 5 (33.3%) 15 (62.5%) 8 (27.6%)

  • Septa

3 (5.7%) 1 (2.6%) 2 (13.3%) 2 (8.3%) 1 (3.4%)
Surgery 47 (88.7%) 35 (92.1%) 12 (80.0%) 0.440 24 (100%) 23 (79.3%) 0.054 25 (92.6%) 20 (87.0%) 0.850
Other treatments 0.572 <0.001 0.335

  • RTH + CTH

6 (11.3%) 5 (13.2%) 1 (6.7%) 0 (0.0%) 6 (20.7%) 3 (11.1%) 3 (13.0%)

  • CTH

3 (3.8%) 1 (2.6%) 2 (13.3%) 0 (0.0%) 2 (6.9%) 1 (3.7%) 0 (0.0%)

  • RTH

2 (5.7%) 2 (5.3%) 0 (0.0%) 0 (0.0%) 3 (10.3%) 3 (11.1%) 0 (0.0%)
Mortality 13 (27.7%) 9 (26.5%) 4 (26.7%) 0.901 0 (0.0%) 13 (50.0%) <0.001 7 (29.2%) 5 (25.0%) 0.999

  • Benign

0 (0%) 0 (0%) 0 (0%) 0.999 - - - 0 (0%) 0 (0%) 0.999

  • Malignant

13 (27.7%) 9 (26.5%) 4 (26.7%) 0.901 - - - 7 (29.2%) 5 (25.0%) 0.999
Recurrence 7 (15.9%) 6 (18.8%) 1 (8.3%) 0.705 0 (0.0%) 7 (26.9%) 0.048 6 (25.0%) 1 (5.9%) 0.237
Follow-up time (days) 180 (60, 365) 165 (67.5, 420) 240 (75, 347.5) 0.739 270 (45, 547.5) 165 (90, 356.25) 0.577 180 (90, 365) 285 (42.75, 652.5) 0.548

CTH = chemotherapy; RTH = radiotherapy. Statistically significant p-values (p < 0.05) are highlighted in bold.